image du produit

La Presse Médicale

Abbonarsi

Sommario

@@150162@@ | @@150163@@

Vol 42 - N° 4P2 - avril 2013

P. 491-790

© Elsevier Masson SAS

16th International Vasculitis & ANCA Workshop

Éditorial
- ·Vasculitides: Roads traveled and avenue to pursue
  
  Pagina :491-492
  
  Loïc Guillevin
  Riassunto Riassunto Mappa Mappa
Lectures
- ·L1. Pathogenesis of ANCA-associated vasculitis: Observations, theories and speculations
  
  Pagina :493-498
  
  J. Charles Jennette, Ronald J. Falk
  Riassunto Riassunto Mappa Mappa
- ·L2. Neutrophil transmigration in vivo: Mechanisms, dynamics and contribution to dissemination of systemic inflammation
  
  Pagina :498-499
  
  Sussan Nourshargh
  Riassunto Riassunto Mappa Mappa
- ·L3. Are mononuclear cells predominant actors of endothelial damage in vasculitis?
  
  Pagina :499-503
  
  Wayel H. Abdulahad, Alexandre W.S. De Souza, Cees G.M. Kallenberg
  Riassunto Riassunto Mappa Mappa
- ·L4. Eosinophils: How they contribute to endothelial damage and dysfunction
  
  Pagina :503-507
  
  Florence Roufosse
  Riassunto Riassunto Mappa Mappa
- ·L5. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
  
  Pagina :507-510
  
  Jean-François Cordier, Vincent Cottin, Loïc Guillevin, Elisabeth Bel, Paolo Bottero, Klaus Dalhoff, Marc Humbert, Romain Lazor, Renato A. Sinico, Pasupathy Sivasothy, Michael E. Wechsler
  Riassunto Riassunto Mappa Mappa
- ·L6. Eosinophilic granulomatosis with polyangiitis: Future therapies
  
  Pagina :510-512
  
  Frank Moosig
  Riassunto Riassunto Mappa Mappa
- ·L7. Animal models of PR3-ANCA vasculitis: Approaches and controversies
  
  Pagina :512-515
  
  Mark A. Little
  Riassunto Riassunto Mappa Mappa
- ·L8. Animal models of ANCA associated vasculitis: The contribution of autoantibodies and autoreactive T cells
  
  Pagina :515-517
  
  Peter Heeringa
  Riassunto Riassunto Mappa Mappa
- ·L9. The role of genetic background in an animal model of ANCA-associated vasculitis
  
  Pagina :517-520
  
  Hong Xiao
  Riassunto Riassunto Mappa Mappa
- ·L10. Animal models of ANCA-associated vasculitis: Effector mechanisms and experimental therapies
  
  Pagina :520-523
  
  Adrian Schreiber
  Riassunto Riassunto Mappa Mappa
- ·L11. Hepatitis C virus mixed cryoglobulinemia vasculitis: Therapeutic options
  
  Pagina :523-527
  
  Patrice Cacoub, Benjamin Terrier, David Saadoun
  Riassunto Riassunto Mappa Mappa
- ·L12. Rheumatoid arthritis vasculitis
  
  Pagina :527-530
  
  Xavier Puéchal
  Riassunto Riassunto Mappa Mappa
- ·S1. Rituximab for ANCA-associated vasculitis: The experience in the United States
  
  Pagina :530-532
  
  Jeremy M. Clain, Ulrich Specks
  Riassunto Riassunto Mappa Mappa
- ·S2. Rituximab for ANCA-associated vasculitis: The UK experience
  
  Pagina :532-534
  
  David Jayne
  Riassunto Riassunto Mappa Mappa
- ·S3. Rituximab for ANCA-associated vasculitides: The French experience
  
  Pagina :534-536
  
  Pierre Charles, Loïc Guillevin
  Riassunto Riassunto Mappa Mappa
- ·L13. Apoptosis, Apoptotic cell clearance and resolution of inflammation
  
  Pagina :536-537
  
  Adriano G. Rossi
  Riassunto Riassunto Mappa Mappa
- ·L14. Immunomodulatory properties of apoptotic cells
  
  Pagina :537-543
  
  Sylvain Perruche, Philippe Saas
  Riassunto Riassunto Mappa Mappa
- ·L15. EULAR/ACR 2012 classification criteria for polymyalgia rheumatica
  
  Pagina :543-546
  
  Eric L. Matteson, EULAR/ACR Study Group for Development of Classification Criteria for Polymyalgia Rheumatica
  Riassunto Riassunto Mappa Mappa
- ·L16. The specificities of pediatric vasculitis classification
  
  Pagina :546-550
  
  Cigdem Yildiz, Seza Ozen
  Riassunto Riassunto Mappa Mappa
- ·L17. What can we expect from the revised Chapel Hill consensus conference nomenclature of vasculitis?
  
  Pagina :550-555
  
  J. Charles Jennette
  Riassunto Riassunto Mappa Mappa
- ·L18. Granuloma formation in granulomatosis with polyangiitis
  
  Pagina :555-558
  
  Konstanze Holl-Ulrich
  Riassunto Riassunto Mappa Mappa
- ·L19. Lymphoid neogenesis in vascular chronic inflammation
  
  Pagina :558-560
  
  Antonino Nicoletti, Jamila Khallou-Laschet, Kevin Guedj, Marc Clement, Anh-Thu Gaston, Marion Morvan, Charles-Antoine Dutertre, Jean-Baptiste Michel, Olivier Thaunat, Giuseppina Caligiuri
  Riassunto Riassunto Mappa Mappa
- ·L20. Memory T-cells in vasculitis
  
  Pagina :560-563
  
  Peter Lamprecht
  Riassunto Riassunto Mappa Mappa
- ·L21. Kidneys in ANCA-associated vasculitis: What to learn from biopsies?
  
  Pagina :563-565
  
  Chinar Rahmattulla, Annelies E. Berden, Ingeborg M. Bajema
  Riassunto Riassunto Mappa Mappa
- ·L22. Crescent formation: Unraveling local mediators that break glomerular epithelial cell tolerance to immune injury
  
  Pagina :565-568
  
  Carole Hénique, Cécile Fligny, Pierre-Louis Tharaux
  Riassunto Riassunto Mappa Mappa
- ·L23. Renal transplantation in ANCA-associated vasculitis
  
  Pagina :568-571
  
  Mårten Segelmark
  Riassunto Riassunto Mappa Mappa
- ·L24. Local treatments of subglottic and tracheal stenoses in granulomatosis with polyangiitis (Wegener’s)
  
  Pagina :571-574
  
  Niels Rasmussen
  Riassunto Riassunto Mappa Mappa
- ·L25. Medical treatment of subglottic stenosis in granulomatosis with polyangiitis (Wegener’s)
  
  Pagina :575-576
  
  Paul A. Monach
  Riassunto Riassunto Mappa Mappa
- ·L26. How antigens influence the disease: An immunologist point of view
  
  Pagina :577-579
  
  Meghan E. Free, Dominic J. Ciavatta, Ronald J. Falk
  Riassunto Riassunto Mappa Mappa
- ·L27. Antibodies versus phenotypes: A clinician’s view
  
  Pagina :579-582
  
  David Jayne
  Riassunto Riassunto Mappa Mappa
- ·L28. Relevance of detection techniques for ANCA testing
  
  Pagina :582-584
  
  Csernok Elena
  Riassunto Riassunto Mappa Mappa
- ·L29. Relevance of anti-LAMP-2 in vasculitis: Why the controversy
  
  Pagina :584-588
  
  Renate Kain
  Riassunto Riassunto Mappa Mappa
- ·L30. Assessment of vasculitis extent and severity
  
  Pagina :588-589
  
  Nicolò Pipitone, Giulia Pazzola, Francesco Muratore, Carlo Salvarani
  Riassunto Riassunto Mappa Mappa
- ·L31. A GWAS in ANCA-associated vasculitis: Will genetics help re-define clinical classification?
  
  Pagina :589-591
  
  Paul A. Lyons, Kenneth G.C. Smith
  Riassunto Riassunto Mappa Mappa
- ·L32. ANCA vasculitis over the world. What do we learn from country differences?
  
  Pagina :591-593
  
  Richard A. Watts, David Gi Scott
  Riassunto Riassunto Mappa Mappa
- ·L33. Neutrophil in immunity: A key modulator
  
  Pagina :594-595
  
  Marco A. Cassatella
  Riassunto Riassunto Mappa Mappa
- ·L34. Neutrophils in ANCA-associated vasculitis: Still under investigation
  
  Pagina :595-597
  
  Véronique Witko-Sarsat
  Riassunto Riassunto Mappa Mappa
- ·L35. Fc receptors and cell activation
  
  Pagina :598-599
  
  Renato C. Monteiro
  Riassunto Riassunto Mappa Mappa
- ·L36. Evidence-based clinical science and art in the diagnosis of central nervous system vasculitis
  
  Pagina :600-602
  
  Leonard H. Calabrese
  Riassunto Riassunto Mappa Mappa
- ·L37. Reversible cerebral vasoconstriction syndrome: Distinction from CNS vasculitis
  
  Pagina :602-604
  
  Anne Ducros
  Riassunto Riassunto Mappa Mappa
- ·L38. How to treat primary vasculitis of the central nervous system
  
  Pagina :605-607
  
  Christian Pagnoux, Hubert de Boysson
  Riassunto Riassunto Mappa Mappa
- ·L39. Fulminant anca vasculitis
  
  Pagina :607-609
  
  Alexandre Karras, Christian Jacquot, Eric Thervet
  Riassunto Riassunto Mappa Mappa
- ·L41. Perspectives on the treatment of giant cell arteritis
  
  Pagina :609-612
  
  Carol A. Langford
  Riassunto Riassunto Mappa Mappa
- ·L42. Morbidity in patients with ANCA-associated vasculitis
  
  Pagina :612-616
  
  Lorraine Harper
  Riassunto Riassunto Mappa Mappa
- ·L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: Different outcomes?
  
  Pagina :616-619
  
  Julia U. Holle
  Riassunto Riassunto Mappa Mappa
- ·L44. Management of relapses in vasculitis
  
  Pagina :619-622
  
  Luc Mouthon
  Riassunto Riassunto Mappa Mappa
- ·L45. Aortitis, retroperitoneal fibrosis, and IgG4-related disease
  
  Pagina :622-625
  
  John H. Stone
  Riassunto Riassunto Mappa Mappa
- ·L46. Novel forms of clinical vasculitis: Anti-GBM vasculitis (Goodpasture’s disease)
  
  Pagina :625-628
  
  Stephen P. McAdoo, Charles D. Pusey
  Riassunto Riassunto Mappa Mappa
- ·L47. Single-organ vasculitis: Conceptual and practical considerations
  
  Pagina :628-634
  
  Alfred Mahr, Maxime Battistella, Jean-David Bouaziz, Séverin Chaigne-Delalande
  Riassunto Riassunto Mappa Mappa
- ·L48. The challenges in assessing Takayasu arteritis
  
  Pagina :634-635
  
  Paul Bacon, Ramnath Misra
  Riassunto Riassunto Mappa Mappa
- ·L49. Percutaneous interventions in Takayasu arteritis
  
  Pagina :635-637
  
  George Joseph
  Riassunto Riassunto Mappa Mappa
- ·L50. The future of international clinical trials in vasculitis
  
  Pagina :637-641
  
  Peter A. Merkel
  Riassunto Riassunto Mappa Mappa
- ·L51. From immunosuppression to selective treatments: The benefit–risk ratio
  
  Pagina :641-643
  
  Loïc Guillevin
  Riassunto Riassunto Mappa Mappa
- ·L52. Vasculitis treatment: Is it time to change the standard of care for ANCA-associated vasculitis?
  
  Pagina :643-650
  
  Gary S. Hoffman
  Riassunto Riassunto Mappa Mappa
Abstracts
- ·Calprotectin amplifies the inflammatory response
  
  Pagina :651
  
  R. Pepper, S. Hamour, H.H. Wang, T. Vogl, T. Cook, C. Pusey, A. Salama
- ·Proteinase 3induces shape change in platelets through activation of the Rho/Rho-kinase signaling pathway
  
  Pagina :651
  
  X. Peng, T. Kurz, C. Brommesson, M. Grenegård, M. Segelmark
- ·Identification of target antigens of anti-endothelial cell antibodies in patients with ANCA-associated systemic vasculitis: A proteomic approach
  
  Pagina :651-652
  
  A. Régent, H. Dib, G. Bussone, N. Tamas, C. Federici, C. Broussard, L. Guillevin, L. Mouthon
  Riassunto Riassunto Mappa Mappa
- ·Proteinase 3 (PR3) is a phosphatidylserine-binding protein that can bind microparticles: Relevance in the context of granulomatosis with polyangiitis (GPA)
  
  Pagina :652
  
  M. Pederzoli-Ribeil, F. Angelot, A. Millet, C. Kantari, N. Reuter, L. Mouthon, P. Frachet, P. Saas, V. Witko-Sarsat
- ·Orthotopic heart transplantation in eosinophilic granulomatosis with polyangiitis
  
  Pagina :652-653
  
  M. Groh, G. Masciocco, E. Kirchner, A. Kristen, G. Bortman, S. Varnous, M. Rosenberg, A. D’armini, C. Pellegrini, A. Brucato, G. Gregorini, M. Frigerio, J.J. Scali, L. Calabrese, L. Guillevin
  Riassunto Riassunto Mappa Mappa
- ·Cluster analysis to explore subclassification of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)
  
  Pagina :653
  
  T. Neumann, F. Moosig, A. Vaglio, J. Zwerina, P. Bremer, A. Gioffredi, J. Grosskreutz, C. Kroegel, F. Maritati, M. Resche-Rigon, A. Mahr
- ·Spleen tyrosine kinase (SYK) inhibition in experimental autoimmune glomerulonephritis (EAG)
  
  Pagina :653-654
  
  S.P. Mcadoo, J. Reynolds, J. Smith, G. Bhangal, E. Masuda, T.H. Cook, C.D. Pusey, F. Tam
  Riassunto Riassunto Mappa Mappa
- ·Serum biomarkers signature identifies patients with overt B-cell non-Hodgkin lymphoma associated with mixed cryoglobulinemia in chronic HCV infection
  
  Pagina :654
  
  B. Terrier, W. Chaara, G. Geri, D. Saadoun, M. Rosenzwajg, D. Sène, A. Six, D. Klatzmann, P. Cacoub
- ·Characterization of drug-induced ANCA vasculitis at Massachusetts’s general hospital (MGH): 1989–2012
  
  Pagina :654-655
  
  W. Pendergraft, M. Mcgrath, A. Murphy, P. Murphy, K. Laliberte, J. Niles
  Riassunto Riassunto Mappa Mappa
- ·High genetic diversity in nasal Staphylococcus aureus isolates from Granulomatosis with Polyangiitis (GPA) patients
  
  Pagina :655
  
  M.M. Van Timmeren, C. Glasner, T. Stobernack, T.F. Omansen, E.C. Raangs, J.W. Rossen, J.P. Arends, G.A. Kampinga, W.J.B. Van Wamel, A. Rutgers, C.A. Stegeman, C.G.M. Kallenberg, P. Heeringa, J.M. Van Dijl
- ·Neutrophils in ANCA vasculitis – old and apathetic
  
  Pagina :655-656
  
  T. Hellmark, Å. Pettersson, D. Selga, A. Bengtsson, Å. Johansson
  Riassunto Riassunto Mappa Mappa
- ·Phagocytosis of apoptotic cells expressing PR3 impaired macrophage anti-inflammatory reprogramming
  
  Pagina :656
  
  A. Millet, J. Mocek, M. Pederzoli-Ribeil, F. Cormier, V. Baud, V. Witko-Sarsat
- ·ANCA disease patients have defective Treg function exacerbated by expansion of a suppression-resistant effector population
  
  Pagina :656
  
  M. Free, D. Bunch, J.A. Mcgregor, C. Poulton, B. Jones, E. Berg, S. Hogan, Y. Hu, G. Preston, C. Jennette, R. Falk, M. Su
- ·Unraveling the identity of FoxP3+ regulatory T cells in GPA-patients
  
  Pagina :656-657
  
  W.H. Abdulahad, C.A. Stegeman, M.G. Huitema, P.C. Limburg, A. Rutgers, P. Heeringa, C.G.M. Kallenberg
  Riassunto Riassunto Mappa Mappa
- ·Performance of the ACR classification criteria as diagnostic criteria for granulomatosis with polyangiitis (GPA) (Wegener’s) in a respiratory referral centre
  
  Pagina :657
  
  F. Contreras-Rodríguez, J. Rojas-Serrano, L.F. Flores-Suárez
- ·Use of the CHCC 2012 definitions in the classification of AAV using the EMA algorithm
  
  Pagina :657
  
  R. Abdulkader, D.G.I. Scott, J. Mooney, S.E. Lane, R.A. Watts
- ·B regulatory cells are numerically but not functionally impaired in AAV
  
  Pagina :658
  
  S.K. Todd, R.J. Pepper, A. Tanna, C. Mauri, A.D. Salama
- ·Nasal mucosa provides a niche for autoreactive plasma cells in granulomatosis with polyangiitis (Wegener’s)
  
  Pagina :658
  
  J. Voswinkel, C. Brieske, E. Csernok, W. Gross, K. Holl-Ulrich, A. Mueller
- ·Dutch transplantation in vasculitis (DUTRAVAS)-study: Update on the outcome of renal transplantation in ANCA-associated vasculitis (AAV) patients in the Netherlands
  
  Pagina :658-659
  
  A. Göçeroğlu, C. Rahmattulla, A.E. Berden, M. Reinders, M.C.R.F. Van Dijk, A.A.E. De Joode, C.J. Peutz-Kootstra, M.H.L. Christiaans, I. Noorlander, R. Goldschmeding, A.D. Van Zuilen, E.J. Steenbergen, L.B. Hilbrands, L. Harper, M.A. Little, E.C. Hagen, J.A. Bruijn, I.M. Bajema
  Riassunto Riassunto Mappa Mappa
- ·Complement pathways activation in pauci-immune necrotizing glomerulonephritis with ANCA
  
  Pagina :659
  
  M.L. Figuères, F. Fakhouri, A. Moreau, Y. Chaabouni, L.H. Noel
- ·Tracheal and bronchial stenoses in granulomatosis with polyangiitis (Wegener) (GPA)
  
  Pagina :659-660
  
  B. Terrier, P. Cohen, X. Puéchal, L. Mouthon, L. Guillevin, For the French Vasculitis Study Group (FVSG)
  Riassunto Riassunto Mappa Mappa
- ·Rituximab therapy for granulomatous poliangeitis (Wegener’s granulomatosis) with refractory granulomatous manifestations
  
  Pagina :660
  
  R. Solans, F. Martinez-Valle, A. Segarra, M. Ramentol, I. Agraz, J.A. Bosch
- ·Upper airway gene expression profiling in granulomatosis with polyangiitis
  
  Pagina :660-661
  
  P. Grayson, K. Steiling, P. Monach, M. Platt, J. Xiao, X. Zhang, Y. Alekseyev, S. Moni, A. Spira, P. Merkel
  Riassunto Riassunto Mappa Mappa
- ·Both histone methylation and acetylation contribute to the aberrant upregulation of proteinase 3 (PR3) and myeloperoxidase (MPO) genes in patients with ANCA disease
  
  Pagina :661
  
  J. Yang, C.J. Poulton, C. Henderson, J.C. Jennette, G. Preston, R. Falk, D. Ciavatta
- ·Reclassifying ANCA-associated vasculitis using the EUVAS algorithm: Epidemiology and survival from the NORVASC register
  
  Pagina :661-662
  
  R. Abdulkader, J. Mooney, C. Sheehy, C. Mukhtyar, D.G.I. Scott, R.A. Watts
  Riassunto Riassunto Mappa Mappa
- ·A myelopoiesis gene signature during remission in ANCA-associated vasculitis reflects ongoing prednisolone therapy and does not seem to predict relapses
  
  Pagina :662
  
  T. Kurz, M. Weiner, C. Skoglund, S. Basnet, P. Eriksson, M. Segelmark
- ·ENT involvement is related to better renal function in patients with ANCA-associated vasculitis
  
  Pagina :662-663
  
  C. Rahmattulla, R.A.F. De Lind Van Wijngaarden, A.E. Berden, H.A. Hauer, O. Floßmann, D.R.W. Jayne, G. Gaskin, N. Rasmussen, L.H. Noël, F. Ferrario, R. Waldherr, C.D. Pusey, E.C. Hagen, J.A. Bruijn, I.M. Bajema
  Riassunto Riassunto Mappa Mappa
- ·Clinical evaluation of a rapid immunofluorescence test (IIFT) for diagnosis of ANCA-associated vasculitis
  
  Pagina :663
  
  L. Bianchi, S. Glionna, B. Trezzi, C. Farina, R.A. Sinico
- ·Prevalence of anti-neutrophil cytoplasmic antibodies in infective endocarditis: An analysis of 109 cases
  
  Pagina :663-664
  
  A. Mahr, F. Batteux, S. Tubiana, M. Wolff, C. Goulvestre, T. Papo, I. Klein, F. Vrtovsnik, B. Iung, X. Duval
  Riassunto Riassunto Mappa Mappa
- ·Recurrent acquired ANCA-positive agranulocytosis after cocaine exposure: A chronic disease?
  
  Pagina :664
  
  F. Schieppati, G. Gregorini, U. Specks, S.M. Eder, A.M. Hummel, G. Rossi
- ·ANCA epitope specificity determines pathogenicity, detectability and clinical predictive value
  
  Pagina :664
  
  A. Roth, J. Ooi, J. Hess, M. Van Timmeren, E. Berg, C. Poulton, J. Mcgregor, M. Burkart, S. Hogan, Y. Hu, W. Winnik, P. Nachman, C. Stegeman, J. Niles, P. Heeringa, M. Free, R. Kitching, S. Holdsworth, C. Jennette, G. Preston, R. Falk
- ·Characteristics and outcomes of patients with ANCA-associated vasculitis in the Czech population
  
  Pagina :664-665
  
  Z. Hruskova, E. Jancova, V. Lanska, J. Svojanovsky, J. Klaboch, P. Nemec, K. Zamboch, M. Kodeda, V. Hanzal, P. Nemejc, V. Tesar, On Behalf Of The Czech National Clinical Registry Of Aav 1
  Riassunto Riassunto Mappa Mappa
- ·Premature ovarian failure in women with ANCA-associated vasculitis
  
  Pagina :665
  
  J. Tuin, J.S. Sanders, A. Hoek, C.A. Stegeman
- ·Infection risk in ANCA-associated vasculitis
  
  Pagina :665-666
  
  M. Morgan, A. Richter, J. Flint, M. Drayson, C. Yiannakis, D. Goldblatt, L. Harper
  Riassunto Riassunto Mappa Mappa
- ·A risk score for predicting short-term incidence of death or relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis
  
  Pagina :666
  
  C. Maldini, M. Resche-Rigon, D. Jayne, K. Westman, A. Mahr
- ·Eosinophilic granulomatosis with polyangiitis (Churg–Strauss) (EGPA), polyarteritis nodosa (PAN) and microscopic polyangiitis (MPA) with no initial Five-Factor Score-defined poor-prognosis factors (FFS = 0): Baseline factors associated with cytotoxic agent and immunomodulator prescription
  
  Pagina :666
  
  M. Samson, X. Puéchal, H. Devilliers, C. Ribi, P. Cohen, B. Bienvenu, C. Pagnoux, L. Mouthon, L. Guillevin
- ·Computerized interstitial fibrosis quantification is the most powerful histological predictor of renal outcome in ANCA-associated vasculitis
  
  Pagina :667
  
  C. Levi, V. Meas-Yedid, C. Daniliuc, J.C. Olivo-Marin, E. Guiard, L. Mouthon, M. Roland, L. Guillevin, C. Jacquot, A. Karras, E. Thervet
- ·The necessity of the addition of interstitial pathological parameters on the glomerular histological classification to predict the long-term outcome in MPO-ANCA-associated RPGN cohort in Japan
  
  Pagina :667
  
  E. Muso, T. Endo, M. Itabashi, Y. Iwasaki, H. Kakita, Y. Tateishi, T. Komiya, T. Ihara, W. Yumura, T. Sugiyama, K. Joh, K. Suzuki
- ·Long-term outcome in patients with both ANCA and GBM positivity
  
  Pagina :667-668
  
  A. Tanna, S. Mcadoo, F. Tam, T. Cairns, M. Griffith, A. Salama, J. Levy, C. Pusey
  Riassunto Riassunto Mappa Mappa
- ·Granulomatosis with polyangiitis (Wegener’s) is associated with HLA-DPB1*04 and EMA6A gene variants. Evidence from a genome-wide analysis
  
  Pagina :668
  
  G. Xie, D. Roschandel, R. Sherva, P. Monach, Y. Lu, T. Kung, K. Carrington, S. Carette, P. Dellaripa, J. Edberg, G. Hoffman, N. Khalidi, C. Langford, A. Mahr, E.W. St. Clair, P. Seo, U. Specks, R. Spiera, J. Stone, S. Ytterberg, S. Raychaudhuri, P. De Bakker, L. Farrer, C. Amos, P. Merkel, K. Siminovitch
- ·ANCA-associated vasculitis in Hispanics: An unrecognized severity
  
  Pagina :668-669
  
  A. Sreih, R. Mandhadi, J. Block
  Riassunto Riassunto Mappa Mappa
- ·Genetic regulation of CD177 – A receptor presenting anti-neutrophil cytoplasmic antigen proteinase 3
  
  Pagina :669
  
  C. Eulenberg, S. Bähring, F. Luft, R. Kettritz
- ·ANCA disease patients with increased expression of autoantigen genes produce an alternative PR3 transcript and synthesize autoantigen proteins
  
  Pagina :669
  
  E. Alderman, A. Badwar, A. Muthigi, C. Allred, J. Yang, O. Lardinois, J.C. Jenette, G. Preston, R. Falk, D. Ciavatta
- ·Long-term outcomes of patients with reversible cerebral vasoconstriction syndrome (RCVS)
  
  Pagina :670
  
  R. Hajj-Ali, S. John, L. Calabrese, M. Stillman, S. Tepper, K. Uchino
- ·Recognizing childhood inflammatory brain diseases in Canada
  
  Pagina :670
  
  M. Twilt, S. Sheikh, T. Cellucci, G. Chedeville, A. Kirton, A. Mineyko, H. Schmelig, D. Pohl, J. Roth, D. Cabral, A. Huber, A. Rosenberg, N. Schiff, S. Benseler
- ·Factors predictive of prognosis in renal AAV – A study of 104 patients in a single UK centre
  
  Pagina :670-671
  
  A. Tanna, G. Laura, F. Tam, T. Cairns, M. Griffith, R. Tarzi, J. Levy, A. Salama, G. Gaskin, T. Cook, C. Pusey
  Riassunto Riassunto Mappa Mappa
- ·Prognosis of patients with ANCA-associated glomerulonephritis (GN) presenting with severe renal failure
  
  Pagina :671
  
  T. Lee, A. Gasim, J.A.G. Mcgregor, V.K. Derebail, C.J. Poulton, S. Lionaki, S.L. Hogan, J.C. Jennette, R.J. Falk, P.H. Nachman
- ·Diffuse alveolar haemorrhage (DAH) in levamisole-adultered cocaine abuser resolved by rFVIIa infusion
  
  Pagina :671-672
  
  E. Pecci, G. Gregorini, P. Sinigaglia, G. Bozzola, G. Tassi, P. Ferremi, N. Latronico
  Riassunto Riassunto Mappa Mappa
- ·ANCA-associated vasculitis (AAV) and thrombotic michroangiopathies (TMA): A retrospective histological study
  
  Pagina :672
  
  L. Manenti, E. Gnappi, L. Signorini, F. Pilato, A. Vaglio, C. Buzio
- ·The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK
  
  Pagina :672-673
  
  J. Robson, A. Kiran, J. Maskell, A. Hutchings, N. Arden, B. Dasgupta, W. Hamilton, D. Culliford, A. Emin, R. Luqmani
  Riassunto Riassunto Mappa Mappa
- ·Risk of cardiovascular disease early and late after a diagnosis of giant cell arteritis
  
  Pagina :673
  
  G. Tomasson, C. Peloquin, A. Mohammad, T. Love, Y. Zhang, H.K. Choi, P.A. Merkel
- ·Large vessel vasculitis: Estimating disease activity in patients with thoracic aortic aneurysms
  
  Pagina :673
  
  A. Clifford, T. Clark, D. Johnston, G. Pettersson, E. Roselli, E. Soltesz, L. Svensson, G. Hoffman
- ·Assessment of disease activity in large vessel vasculitis: Initial results of an international Delphi exercise
  
  Pagina :673-674
  
  S.Z. Aydin, H. Direskeneli, E. Matteson, P.A. Merkel
  Riassunto Riassunto Mappa Mappa
- ·Outcome and prognostic factors in elderly patients with ANCA-associated vasculitis
  
  Pagina :674
  
  M. Weiner, S.M. Goh, A. Mohammad, Z. Hrušková, A. Tanna, A. Bruchfeld, D. Selga, Q. Ko, K. Westman, P. Eriksson, C. Pusey, V. Tesar, A. Salama, M. Segelmark
- ·Factors associated with major cardiovascular events in patients with primary systemic necrotizing vasculitides: Results of a longitudinal long-term follow-up study
  
  Pagina :674-675
  
  B. Terrier, C. Pagnoux, G. Chironi, A. Simon, L. Mouthon, L. Guillevin
  Riassunto Riassunto Mappa Mappa
- ·Outcomes in patients with granulomatosis with polyangiitis (Wegener’s) treated with short vs. long-term maintenance therapy
  
  Pagina :675
  
  J. Springer, B. Nutter, C. Langford, G. Hoffman, A. Villa-Forte
- ·Characteristics and outcome of patients with granulomatosis with polyangiitis (Wegener’s) and microscopic polyangiitis on renal replacement therapy – Data from the ERA-EDTA registry
  
  Pagina :675
  
  Z. Hruskova, V.S. Stel, D.R. Jayne, V. Tesar, K.J. Jager, On Behalf Of The National/Regional Renal Registry Representatives In Europe 2
- ·Occupational and environmental risk factors in chronic periaortitis: A case-control study
  
  Pagina :675-676
  
  M.L. Urban, S. Bonini, A. Mutti, C. Buzio, A. Vaglio
  Riassunto Riassunto Mappa Mappa
- ·Behçet’s disease in Budd-Chiari Syndrome
  
  Pagina :676
  
  A.C. Desbois, P.E. Rautou, A. Plessier, N. Belmatoug, M. Pineton De Chambrun, B. Wechsler, M. Resche-Rigon, B. Fantin, D. Valla, P. Cacoub, D. Saadoun
- ·The unmet need in Behçet’s disease: Most patients are not in complete remission in the long-term follow-up
  
  Pagina :676-677
  
  F. Alibaz-Oner, G. Mumcu, G. Ozen, Z. Kubilay, M. Can, S. Yılmaz Oner, T. Ergun, H. Direskeneli
  Riassunto Riassunto Mappa Mappa
- ·Cutaneous vasculitis: Report of 117 cases
  
  Pagina :677
  
  P. Fanlo, A. Villanueva, S. Clemos, C. Perez, R. Guarch, M. Montes
- ·Takayasu arteritis – An outcome study in a UK cohort
  
  Pagina :677
  
  T. Youngstein, J. Mason
- ·Biologic agents offer an effective long-term therapeutic option for refractory Takayasu arteritis
  
  Pagina :677-678
  
  T. Youngstein, J. Peters, J. Mason
  Riassunto Riassunto Mappa Mappa
- ·Assessment of patients with Takayasu’s arteritis in a routine clinical follow-up with Indian Takayasu Clinical Activity Score (ITAS2010)
  
  Pagina :678
  
  F. Alibaz-Oner, H. Direskeneli
- ·A randomized trial of mycophenolate mofetil versus cyclophosphamide for remission induction of ANCA-associated vasculitis: “MYCYC”. On behalf of the European vasculitis study group
  
  Pagina :678-679
  
  R. Jones, L. Harper, J. Ballarin, D. Blockmans, P. Brogan, A. Bruchfeld, M. Cid, K. Dahlsveen, J. Dezoysa, P. Lanyon, C.A. Peh, V. Tesar, A. Vaglio, M. Walsh, D. Walsh, G. Walters, D. Jayne
  Riassunto Riassunto Mappa Mappa
- ·Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. A prospective study in 117 patients
  
  Pagina :679
  
  L. Guillevin, C. Pagnoux, A. Karras, C. Khouatra, O. Aumaitre, P. Cohen, O. Decaux, H. Desmurs-Clavel, P. Gobert, T. Quemeneur, C. Blanchard-Delaunay, P. Godmer, X. Puechal, P.L. Carron, P.Y. Hatron, N. Limal, M. Hamidou, B. Bonnotte, P. Ravaud, L. Mouthon, for the FVSG
- ·Treatment of systemic necrotizing vasculitides in patients ≥ 65 years old: Results of the multicenter randomized CORTAGE trial
  
  Pagina :679-680
  
  C. Pagnoux, T. Quéméneur, J. Ninet, E. Perrodeau, E. Diot, X. Kyndt, B. De Wazières, J.L. Reny, X. Puéchal, P.Y. Leberruyer, O. Lidove, P. Vanhille, P. Godmer, A. Albath-Sadiki, B. Bienvenu, P. Cohen, L. Mouthon, P. Ravaud, L. Guillevin, FVSG 16
  Riassunto Riassunto Mappa Mappa
- ·Randomized clinical trial of extended versus standard azathioprine maintenance therapy in newly diagnosed PR3-ANCA positive vasculitis patients at high-risk for disease relapse
  
  Pagina :680
  
  A.A.E. De Joode, J.S. Sanders, J.W. Cohen Tervaert, C.A. Stegeman
Posters
- ·The diagnostic value of distinguishing and reporting different perinuclear ANCA (P-ANCA) immunofluorescence patterns: A prospective study
  
  Pagina :681
  
  S. Perel, K. Prain, R. Wilson, R. Wong, D. Gillis, P. Hogan
- ·ANCA testing in routine clinical laboratory
  
  Pagina :681-682
  
  I. Lochman, A. Lochmanová
  Riassunto Riassunto Mappa Mappa
- ·Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis relapses? Results of a longitudinal study on 126 patients
  
  Pagina :682
  
  L.H. Thai, P. Charles, M. Resche-Rigon, L. Guillevin
- ·Results of ANCA standardisation and their diagnostic usefulness in ANCA-associated vasculitides (AASV) in a respiratory referral centre in Mexico
  
  Pagina :682-683
  
  F. Contreras-Rodríguez, J. Rojas-Serrano, J.E. Figueroa-Aguirre, L.F. Flores-Suárez
  Riassunto Riassunto Mappa Mappa
- ·Incidence of PR3- and MPO-ANCA autoantibody specificity changes in ANCA associated vasculitis
  
  Pagina :683
  
  S. Holding, M. Abuzakouk
- ·Multi-center evaluation of a novel chemiluminescent rapid assay for the detection of PR3-ANCA
  
  Pagina :683-684
  
  M. Mahler, C. Bentow, A. Vizjak, A. Radice, J. Damoiseaux, M. Miyara, G. Engstler, E. Csernok, M. Fritzler, S. Polanski, J. Wilanska, D. Blockmans, X. Bossuyt
  Riassunto Riassunto Mappa Mappa
- ·Comparison of PR3-specific ANCA assays performance for diagnosis of granulomatosis with polyangiitis (GPA)
  
  Pagina :684
  
  A. Radice, L. Bianchi, S. Glionna, B. Trezzi, U. Maggiore, R.A. Sinico
- ·PR3-ANCA: A promising biomarker for the differentiation of ulcerative colitis and Crohn’s disease
  
  Pagina :684
  
  M. Mahler, C. Bentow, D. Blockmans, S. Vermeire, P. Rutgeerts, X. Bossuyt
- ·The association of IgM ANCA with alveolar hemorrhage revisited
  
  Pagina :685
  
  J. Clain, U. Specks, J. Stone
- ·Computer-aided immunofluorescence microscopy (CAIFM) for ANCA diagnostics
  
  Pagina :685
  
  N. Hochstrate, C. Krause, K. Ens, M. Danckwardt, C. Feirer, K. Affeldt, M. Rateike, M. Morrin, D. Wuttig, J. Voigt, K. Fechner, E. Barth, T. Martinetz, W. Stöcker
- ·Patients positive for both MPO-ANCA and PR3-ANCA do not present idiopathic systemic necrotizing vasculitis
  
  Pagina :685-686
  
  A. Chevailler, J.-F. Augusto, J.-F. Subra, D. Lakomy, N.-O. Olsson, A.-S. Denomme, X. Puechal
  Riassunto Riassunto Mappa Mappa
- ·Aklides^® – a highly versatile imaging platform for detection of ANCA
  
  Pagina :686
  
  I. Knütter, K. Grossmann, R. Hiemann, D. Reinhold, E. Csernok, D. Roggenbuck
- ·Synergistic effect of GCSF and LPS in ANCA Vasculitis
  
  Pagina :686-687
  
  R. Popat, S. Freeley, M. Robson
  Riassunto Riassunto Mappa Mappa
- ·Pathogenic leukocytosis and their susceptibility QTLs for vasculitis and crescentic glomerulonephritis in a model of SCG/Kj mice
  
  Pagina :687
  
  H. Yoshitomo, Y. Wako, M. Naoki, S. Kazuo
- ·Implication of vascular endothelial cell-reactive invariant NKT cells in pathogenesis of small vessel vasculitis in rats
  
  Pagina :687
  
  A. Ishizu, U. Tomaru, C. Iinuma, M. Waki, M. Yamaguchi, A. Kawakami, N. Sasaki, T. Yoshiki
- ·Anti TNF-⍺ drug inhibits initial process of vasculitis in animal model of Kawasaki disease
  
  Pagina :687-688
  
  T. Oharaseki, Y. Yokouchi, H. Yamada, N. Ohno, T. Saji, K. Suzuki, S. Naoe, K. Takahashi
  Riassunto Riassunto Mappa Mappa
- ·The role of quantitative trait loci (QTL) in the pathogenesis of experimental autoimmune vasculitis (EAV)
  
  Pagina :688
  
  J.P. Mcdaid, A. Tanna, G. Bhangal, M.A. Little, J. Behmoaras, H.T. Cook, F.W. Tam, A.D. Salama, C.D. Pusey
- ·The protective role of NADPH oxidase in ANCA-induced vasculitis
  
  Pagina :688-689
  
  A. Schreiber, S. Krueger, C. Luft, R. Kettritz
  Riassunto Riassunto Mappa Mappa
- ·Investigating Annexin-A1 in ANCA vasculitis and glomerulonephritis
  
  Pagina :689
  
  P. Jukes, F. D’acquisto, R. Pepper, Y. Ghani, M. Perretti, A. Salama, M. Little
- ·Immunization of NOD mice with recombinant mouse proteinase 3 causes immune complex not pauci-immune crescentic glomerulonephritis
  
  Pagina :689-690
  
  P. Hu, H. Xiao, R. Falk, C. Jennette
  Riassunto Riassunto Mappa Mappa
- ·Infliximab for Behçet disease with aortic involvement
  
  Pagina :690
  
  M. Okada, M. Kishimoto
- ·Infliximab treatment of resistant uveitis in Behçet disease
  
  Pagina :690
  
  R. Becvar, A. Landova, E. Rihova
- ·Behçet’s disease in children: The Great Ormond Street Hospital experience
  
  Pagina :691
  
  S. Nanthapisal, D. Eleftheriou, Y. Hong, N. Klein, P.A. Brogan
- ·Refractory cutaneous vasculitis associated with MAGIC syndrome: Case report
  
  Pagina :691
  
  M. Mellado, P. Fanlo, E. Bidegain, M. Lopez De Goicoechea, M. Garcia Carasusan, J.M. Arejola
- ·Behçet’s disease and pregnancy
  
  Pagina :691-692
  
  N. Noel, B. Wechsler, J. Nizard, N. Costedoat-Chalumeau, D. Le Thi Huong Boutin, D. Vauthier-Brouzes, M. Dommergues, P. Cacoub, D. Saadoun
  Riassunto Riassunto Mappa Mappa
- ·Outcome of neuro-Behçet: Analysis of a large cohort
  
  Pagina :692
  
  N. Noel, B. Wechsler, D. Le Thi Huong Boutin, D. Dormont, P. Cacoub, D. Saadoun
- ·Vessel wall characteristics using high-resolution magnetic resonance imaging in reversible cerebral vasoconstriction syndrome and central nervous system vasculitis
  
  Pagina :692
  
  R. Cerejo, T. Hammad, E. Obusez, S. John, K. Uchino, S. Jones, F. Hui, L. Calabrese, R. Hajj-Ali
- ·Vessel wall characteristics using high-resolution magnetic resonance imaging in reversible cerebral vasoconstriction syndrome and central nervous system vasculitis
  
  Pagina :693
  
  R. Hajj-Ali, R. Cerejo, T. Hammad, E. Obusez, S. John, K. Uchino, S. Jones, F. Hui, L. Calabrese
- ·Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey
  
  Pagina :693
  
  B. Terrier, I. Marie, D. Launay, E. Plaisier, P. Belenotti, J.-E. Kahn, P. Rullier, X. Mariette, P. Cacoub
- ·Characteristics of patients with infectious cryoglobulinemia vasculitis in the absence of HCV infection: Results from the French nationwide CryoVas survey
  
  Pagina :694
  
  B. Terrier, I. Marie, P. Belenotti, F. Bonnet, L. Chiche, A. Hot, J.-E. Kahn, T. Quemeneur, X. Mariette, E. Plaisier, P. Cacoub
- ·Ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis/Peg-IFNa/
  
  Pagina :694-695
  
  D. Saadoun, S. Pol, J.M. Ziza, G. Pialoux, A. Karras, O. Lambotte, P. Cacoub
  Riassunto Riassunto Mappa Mappa
- ·Many faces of cutaneous vasculitis in eosinophilic granulomatosis with polyangiitis: An excellent model for histopathology of cutaneous vasculitis
  
  Pagina :695
  
  K.R. Chen
- ·A case of relapse of Churg-Strauss syndrome (CSS) with crescentic lesions
  
  Pagina :696
  
  F. Yoshikazu
- ·Copy number variations of FCGR3B in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
  
  Pagina :696
  
  F. Bonatti, A. Gioffredi, F. Maritati, F. Alberici, M.L. Urban, A. Palmisano, E. Oliva, L. Manenti, B. Tumiati, A. Pesci, P. Fraticelli, G. Guida, G. Moroni, D. Roccatello, G. Gregorini, R.A. Sinico, T.M. Neri, C. Buzio, D. Martorana, A. Vaglio
- ·Methotrexate vs cyclophosphamide as maintenance therapy in severe eosinophilic granulomatosis with polyangitiis (Churg Strauss): A subanalysis of the powercime trial
  
  Pagina :696-697
  
  F. Maritati, M.L. Urban, E. Oliva, F. Alberici, A. Vaglio, C. Buzio
  Riassunto Riassunto Mappa Mappa
- ·Clinical assessment of asthma severity partially corresponds to sputum eosinophilic airway inflammation in allergic eosinophilic granulomatosis with polyangiitis
  
  Pagina :697
  
  M. Latorre, C. Baldini, V. Seccia, F. Novelli, S. Bombardieri, P.L. Paggiaro
- ·Clinical value of commonly measured laboratory tests in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
  
  Pagina :697-698
  
  P. Grayson, P. Monach, D. Cuthbertson, S. Carette, G. Hoffman, N. Khalidi, C. Koening, C. Langford, K. Mckinnon-Maksimowicz, C. Pagnoux, P. Seo, U. Specks, S. Ytterberg, P. Merkel
  Riassunto Riassunto Mappa Mappa
- ·A multicenter survey of rituximab for eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
  
  Pagina :698
  
  A. Hot, M.J. Guerry, R. Smith, P. Sivasothy, L. Guillevin, P. Merkel, D. Jayne
- ·Limited otological eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) – a new disease subset
  
  Pagina :699
  
  J. Der Kureghian, N. Donnelly, P. Axon, P. Jani, D. Jayne
- ·The ear, nose and throat manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
  
  Pagina :699
  
  J. Der Kureghian, P. Jani, D. Jayne
- ·ANCA-positive and ANCA-negative phenotypes of eosinophilic granulamatosis and polyangiitis (EGPA): Outcome and long-term follow-up of 46 patients from a single Polish centre
  
  Pagina :699-700
  
  W. Szczeklik, B. Sokolowska, P. Kuczia, J. Gasior, M. Maga, S. Bartyzel, J. Musial
  Riassunto Riassunto Mappa Mappa
- ·A scoring tool for ear, nose and throat disease activity and damage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
  
  Pagina :700
  
  J. Der Kureghian, P. Jani, D. Jayne
- ·Serum biomarkers during relapsing disease in eosinophilic granulomatosis with polyangiitis
  
  Pagina :700-701
  
  C. Dejaco, P. Monach, D. Cuthbertson, S. Carette, G. Hoffman, N. Khalidi, C. Koening, C. Langford, K. Mckinnon-Maksimowicz, P. Seo, U. Specks, S. Ytterberg, P. Merkel, J. Zwerina
  Riassunto Riassunto Mappa Mappa
- ·Eosinophilic granulomatosis with polyangitis (EGPA): Clinical and immunologic expression in a single center cohort
  
  Pagina :701
  
  C. Baldini, M. Latorre, V. Seccia, A. Della Rossa, A. Tavoni, P.L. Paggiaro, S. Sellari Franceschini, S. Bombardieri
- ·Sinonasal involvement in patients with eosinophilic granulomatosis with polyangitis (EGPA, ex Churg Strauss Syndrome): A modern look to an ancient problem
  
  Pagina :701
  
  V. Seccia, C. Baldini, M. Latorre, S. Fortunato, L. Cristofani-Mencacci, P.L. Paggiaro, S. Sellari-Franceschini, S. Bombardieri
- ·A case of eosinophilic granulomatosis with polyangiitis (EGPA) who relapsed with saddle nose
  
  Pagina :701-702
  
  M. Saito, Y. Komagata, T. Takahashi, A. Isomura, S. Kawashima, K. Fukuoka, M. Karube, K. Yoshihara, S. Kaname, Y. Arimura, A. Yamada
  Riassunto Riassunto Mappa Mappa
- ·Referral causes and initial diagnosis of ANCA-associated vasculitides in a pulmonary tertiary centre. Retrospective study in 90 patients
  
  Pagina :702
  
  L.F. Flores-Suárez, M. Alba
- ·ANCA in Auckland 1998–2008
  
  Pagina :702-703
  
  J. De Zoysa, J. Kendrick Jones, M. Lam, M. Yehia
  Riassunto Riassunto Mappa Mappa
- ·Microscopic polyangiitis in the setting of usual interstitial pneumonia
  
  Pagina :703
  
  K. Keogh, M. Baqir, U. Specks, G. Aughenbaugh, G. Battaglia, F. Londrino, A. Tironi, S. Monti, G. Gina
- ·Incidence of granulomatosis with polyangiitis (Wegener’s) among Greenlanders
  
  Pagina :703
  
  M. Faurschou, M. Helleberg, N. Obel, B. Baslund
- ·ANCA-associated vasculitides (AAV) from the gender point of view
  
  Pagina :703-704
  
  A. Radice, L. Bianchi, S. Glionna, B. Trezzi, R.A. Sinico
  Riassunto Riassunto Mappa Mappa
- ·Anti-neutrophil cytoplasmic antibodies associated vasculitis frequency in Dr. Manuel Quintela university hospital
  
  Pagina :704
  
  N. Rodriguez Sisniega, E. Araujo, C. Buzzi, N. Garcia, P. Lopez, C. Montenegro, R. Balleste, L. Borche
- ·Epidemiologic study of primary systemic vasculitides in adults in Southeastern Spain (Costa del Sol Occidental region, Málaga)
  
  Pagina :705
  
  C. Romero-Gómez, J.A. Aguilar-García, M.D. García De Lucas, R. Cotos-Canca, J.J. García-Alegría, J. Hernández-Rodríguez
- ·Pattern of renal involvement and its correlation with outcomes in patients with small and medium vessel vasculitis – experience from a tertiary care center in India
  
  Pagina :705-706
  
  A. Sharma, T. Mittal, M. Rathi, R. Nada, R. Rajan, R. Minz, K. Joshi, S. Singh, V. Sakhuja
  Riassunto Riassunto Mappa Mappa
- ·Pandemic influenza vaccine in granulomatosis with polyangiitis: Adequate humoral response and safety in inactive patients
  
  Pagina :706
  
  N.E. Aikawa, A.L. Calich, S.K. Shinjo, A.C. Medeiros, M. Levy-Neto, V.S. Viana, J.C. Moraes, M.D.C. Timenetsky, E. Bonfa, R.M. Pereira
- ·The association of granulomatosis with polyangiitis and IgG4-related disease: A case series
  
  Pagina :706-707
  
  L. Dudley, L. Brown, J. Pettus, C. Black, N. Orzechowski
  Riassunto Riassunto Mappa Mappa
- ·Multiple infections in a Filipino with polyangiitis overlap syndrome (POS)
  
  Pagina :707
  
  G. Racaza, L. Abrahan Iv, K.A. Reyes, E. Penserga
- ·Cardiovascular risk in different variants of granulomatosis with polyangiitis (Wegener’s)
  
  Pagina :707-708
  
  E. Kuznetsova, S. Moiseev, P. Novikov
  Riassunto Riassunto Mappa Mappa
- ·Long-term follow-up of 96 GPA patients at a single centre
  
  Pagina :708
  
  F. Rees, M. Al-Deiri, P. Lanyon
- ·Analysis of whole-blood micro-rna profiles in PR-3-ANCA positive vasculitis
  
  Pagina :708
  
  T. Kirsch, A. Bertram, S. Lovric, J.K. Park, J. Becker, M. Haubitz
- ·Successful pregnancy in patients with granulomatosis with polyangiitis (Wegener’s) after rituximab treatment
  
  Pagina :709
  
  P. Novikov, E. Kuznetsova, O. Borodin, A. Meshkov, S. Moiseev
- ·Distinct eicosanoid profile in exhaled breath condensates from granulomatosis with polyangiitis (Wegener’s) patients
  
  Pagina :709
  
  W. Szczeklik, M. Sanak, J. Sznajd, B. Jakieła, B. Sokołowska, M. Kaszuba, A. Sawina, J. Musial
- ·Alveolar hemorrhage, rectus muscle hematoma, and gastrointestinal bleeding accompanied by crescentic glomerulonephritis in a patient with PR3-ANCA disease
  
  Pagina :709-710
  
  Y. Cao
  Riassunto Riassunto Mappa Mappa
- ·Characterization of F-18 fluorodeoxyglucose PET/CT in granulomatosis with polyangiitis
  
  Pagina :710
  
  D. Nelson, G. Johnson, R. Cartin-Ceba, U. Specks
- ·Presentation and management of granulomatosis with polyangiitis (Wegener’s) (GPA) central nervous system (CNS) involvement
  
  Pagina :710
  
  G. De Luna, B. Terrier, P. Charles, C. Pagnoux, X. Puechal, P. Cohen, L. Mouthon, L. Guillevin
- ·Pituitary dysfunction in granulomatosis with polyangiitis
  
  Pagina :710-711
  
  R. Cartin-Ceba, E. Singh, T. Peikert, K. Keogh, D. Erickson, U. Specks
  Riassunto Riassunto Mappa Mappa
- ·Inter-observer reproducibility of two CT scan staging systems to evaluate sinonasal involvement in granulomatosis with polyangiitis (Wegener’s)
  
  Pagina :711
  
  P. Díaz, G. Faba, D. Contreras, R. Zunino, C. Ortega, F. Silva
- ·Pathogenesis of atherosclerosis in granulomatosis with polyangiitis
  
  Pagina :711
  
  R. Hajj-Ali, G. Hoffman, R. Silverstein, T. Clark, C. Langford
- ·Maintenance treatment in childhood granulomatosis with polyangiitis
  
  Pagina :712
  
  M. Twilt, R. Schneider, D. Hebert, E. Harvey, R. Laxer, S. Dell, C. Licht, S. Benseler
- ·GPA and MPA patients have different serum cytokine profiles
  
  Pagina :712
  
  A. Avik, Y. Sundström, L. Berg, A. Bruchfeld, V. Malmström, I. Gunnarsson
- ·A case of lung biopsy-proven MPO-ANCA positive granulomatosis with polyangiitis (GPA; Wegener’s granulomatosis)
  
  Pagina :712-713
  
  K. Murakami, M. Saito, Y. Komagata, K. Yoshihara, S. Kaname, Y. Arimura, A. Yamada, Y. Nakamoto, M. Ishida, M. Hikgaki, H. Takizawa, R. Kawauchi, T. Goya, M. Fujiwara, T. Yazawa, H. Kamma
  Riassunto Riassunto Mappa Mappa
- ·Interleukin 15, CD56+ T-cells and ANCA-associated vasculitis (AAV)
  
  Pagina :713
  
  B.M. Buhl, C. Stegeman, C.G.M. Kallenberg, A. Rutgers, W.H. Abdulahad
- ·Resolution of proteinuria and hematuria in ANCA-associated nephritis
  
  Pagina :713
  
  S. Lilliebladh, A. Mohammad, K. Westman, M. Segelmark
- ·Central nervous system involvement in granulomatous polyangiitis (GPA)
  
  Pagina :714
  
  O. Karadag, O. Helvaci, I. Dogan, U. Kalyoncu, A. Akdogan, L. Kilic, S. Kiraz
- ·Clinical manifestations of granulomatosis with polyangiitis (Wegener’s granulomatosis) in the upper respiratory tracts
  
  Pagina :714
  
  O. Iaremenko, L. Petelytska
- ·Immunopathology of active and remitting granulomatosis with poyangiitis (Wegener’s)
  
  Pagina :714-715
  
  L. Rani, R. Minz, A. Sharma, S. Anand, D. Gupta, N. Panda, V. Sakhuja
  Riassunto Riassunto Mappa Mappa
- ·Tracheobronchial stenoses (TBS) in granulomatosis with polyangiitis (Wegener) (GPA)
  
  Pagina :715
  
  C. Girard, V. Cottin, J.-F. Cordier, L. Guillevin
- ·Wegener or Churg Strauss
  
  Pagina :715
  
  S. Saliba
- ·Predicting relapse in granulomatosis with polyangiitis: The role of biomarkers
  
  Pagina :716
  
  P. Hogan, R. O’connell, E. Browne, S. Scollard, E. Hackett, C. Feighery
- ·Circulating gamma delta T cells are significantly reduced in granulomatosis with polyangiitis
  
  Pagina :716
  
  S. Scollard, B. Mangan, D. Doherty, N. Conlon, C. Feighery
- ·Proteinase 3 reactive T cells in patients with granulomatosis with polyangiitis
  
  Pagina :716
  
  S. Scollard, R. Comerford, N. Conlon, C. Feighery
- ·Vitamin D level is decreased in patients with Takayasu’s arteritis
  
  Pagina :716-717
  
  F. Alibaz-Oner, O. Asmaz Haliloglu, D. Gogas Yavuz, M. Can, H. Direskeneli
  Riassunto Riassunto Mappa Mappa
- ·Presence of fibromyalgia and fatigue is not increased in patients with Takayasu’s arteritis
  
  Pagina :717
  
  F. Alibaz-Oner, M. Can, B. Ilhan, O. Polat, H. Direskeneli
- ·Impaired endothelial function in patients with Takayasu’s arteritis
  
  Pagina :717-718
  
  F. Alibaz-Oner, S. Yurdakul, S. Aytekin, H. Direskeneli
  Riassunto Riassunto Mappa Mappa
- ·Impairment in aortic elastic properties and mechanics of carotid artery system in patients with Takayasu’s arteritis
  
  Pagina :718
  
  F. Alibaz-Oner, S. Yurdakul, S. Aytekin, H. Direskeneli
- ·The higher response of pandemic influenza vaccination in Takayasu’arteritis: A prospectively controlled study
  
  Pagina :718-719
  
  A.L. Calich, S.T. Shinjo, A.C. Ribeiro, N.E. Aikawa, M. Levy-Neto, C.G. Saad, A.R. Precioso, M.D.C. Timenetsky, E. Bonfa, R.M. Pereira
  Riassunto Riassunto Mappa Mappa
- ·Takayasu’s arteritis in southern Sweden
  
  Pagina :719
  
  A. Mohammad, T. Mandl
- ·ITAS.A suggests persistent disease activity in Takayasu aorto-arteritis after 6 months induction therapy
  
  Pagina :719
  
  P. Bacon
- ·Outcome of vascular interventions in Takayasu arteritis
  
  Pagina :720
  
  M. Rajappa
- ·14-3-3 in large vessel vasculitis: A novel antigen
  
  Pagina :720
  
  R. Chakravarti, K. Gupta, L. Svensson, E. Roselli, G. Pettersson, D. Johnston, E. Soltesz, T. Daly, D. Stuehr, G. Hoffman
- ·Methotrexate plus prednisone in patients with relapsing chronic periaortitis
  
  Pagina :720-721
  
  F. Alberici, A. Palmisano, M.-L. Urban, F. Maritati, E. Oliva, L. Manenti, S. Ferretti, R. Cobelli, C. Buzio, A. Vaglio
  Riassunto Riassunto Mappa Mappa
- ·Outcome of 1516 percutaneous interventions in 401 patients with Takayasu arteritis – a single-center experience from South India
  
  Pagina :721
  
  G. Joseph, D. Danda
- ·Aortic dissection in giant cell arteritis: A population-based study of predictors
  
  Pagina :721-722
  
  T. Kermani, K. Warrington, C. Crowson, G. Hunder, S. Ytterberg, S. Gabriel, E. Matteson
  Riassunto Riassunto Mappa Mappa
- ·Patients with Takayasu’s arteritis having persistent acute phase response usually have an increased major vessel uptake by 18F-FDG-PET
  
  Pagina :722
  
  F. Alibaz-Oner, F. Dede, T. Ones, H.T. Turoglu, H. Direskeneli
- ·Can serum procalcitonin help to diagnose patients with new onset giant cell arteritis?
  
  Pagina :722
  
  A.P. Diamantopoulos, H. Hetland, G. Myklebust, D.M. Soldal, G. Haugeberg
- ·Large vessel giant cell arteritis: Clinical, imaging characteristics and outcomes
  
  Pagina :722-723
  
  T. Kermani, F. Muratore, C. Crowson, A. Green, E. Matteson, K. Warrington
  Riassunto Riassunto Mappa Mappa
- ·Efficacy of long-term treatment with TNF inhibitors in patients with refractory Takayasu arteritis
  
  Pagina :723
  
  P. Novikov, I. Smitienko, S. Moiseev
- ·Serum osteopontin in giant cell arteritis: A biomarker associated with sistemic inflammatory response and relapsing course
  
  Pagina :723
  
  S. Prieto-González, M. Corbera-Bellalta, E. Planas-Rigol, A. García-Martínez, M.A. Alba, I. Tavera-Bahillo, G. Espígol-Frigolé, J. Hernández-Rodríguez, M.C. Cid
- ·ANCA-associated systemic vasculitis is associated with impaired dilatory capacity of the conduit brachial artery – a link to increased cardiovascular risk?
  
  Pagina :723-724
  
  P. Clausen, W. Szpirt, B. Feldt-Rasmussen
  Riassunto Riassunto Mappa Mappa
- ·Normal frequencies of circulating Th1 and Th17 cells in GCA patients
  
  Pagina :724
  
  K. Van Der Geest, W. Abdulahad, G. Horst, A. Rutgers, E. Brouwer, A. Boots
- ·Initial presentation of giant cell arteritis with ischemic optic neuropathy without headache: Report of four cases
  
  Pagina :724
  
  V. Duro, C. Perez, P. Fanlo, I. Elejalde, M. Etxebarria, M. Gonzalez
- ·Rapid control of disease activity by Tocilizumab in ten “difficult-to-treat” cases of Takayasu arteritis
  
  Pagina :725
  
  R. Goel, D. Danda, S. Kumar, G. Joseph
- ·Chronic periaortitis and autoimmune thyroiditis: A novel association
  
  Pagina :725
  
  M.L. Urban, G. Ceresini, A. Palmisano, D. Corradi, E. Usberti, C. Buzio, A. Vaglio
- ·Tocilizumab in refractory Takayasu arteritis: Case series and literature review
  
  Pagina :725-726
  
  N. Abisror, A. Mekinian, C. Lavigne, M.-A. Vandenehende, M. Soussan, O. Fain
  Riassunto Riassunto Mappa Mappa
- ·Study of side effects of glucocorticoid treatment in 28 patients with giant cell arteritis (GCA)
  
  Pagina :726
  
  E. Huarte, P. Fanlo, B. Lacruz, U. Gutierrez, F. García Bragado, F. Jimenez, R. Arnáez
- ·Leflunomide as a corticosteroid-sparing agent in giant cell arteritis (GCA) and polymyalgia rheumatica (PMR): A consecutive case series
  
  Pagina :726-727
  
  H. Hetland, G. Myklebust, A.P. Diamantopoulos
  Riassunto Riassunto Mappa Mappa
- ·Tocilizumab for the treatment of giant cell arteritis: Extended follow-up
  
  Pagina :727
  
  S. Unizony, B. Keroack, J.H. Stone
- ·Severe relapse of Takaysu arteritis on ongoing treatment with tocilizumab
  
  Pagina :727
  
  R. Gunnarsson, Ø. Midtvedt, Ø. Palm, E. Merckoll, K. Johnsrud
- ·Asymptomatic myocardial ischemic disease in Takayasu’s arteritis: Detection by magnetic resonance imaging
  
  Pagina :728
  
  C. Comarmod, P. Cluzel, N. Costedoat-Chalumeau, R. Isnard, F. Koskas, P. Cacoub, D. Saadoun
- ·Systemic large vessel vasculitis pattern in chronic periaortitis: Identification of a new disease subset
  
  Pagina :728
  
  A. Palmisano, M.L. Urban, F. Alberici, F. Maritati, C. Salvarani, C. Buzio, A. Vaglio
- ·A single centre experience of 40 children with Takayasu arteritis from India
  
  Pagina :728-729
  
  R. Goel, D. Danda, S. Kumar, G. Joseph
  Riassunto Riassunto Mappa Mappa
- ·IgG4 in chronic periaortitis
  
  Pagina :729
  
  E. Oliva, F. Maritati, A. Palmisano, F. Alberici, C. Buzio, A. Vaglio
- ·Takayasu arteritis (TA) and sacroiliitis. A large vessels vasculitis masquerade from anti-TNF alpha therapy
  
  Pagina :729
  
  P. Toniati, A. Tincani
- ·ITAS.A suggests persistent disease activity in Takayasu aorto-arteritis (TA) after induction therapy
  
  Pagina :729-730
  
  R. Misra, D.P. Misra, D. Danda, A. Lawrence, P.A. Bacon
  Riassunto Riassunto Mappa Mappa
- ·Chronic asymptomatic aortic dissection (AD) in Takayasu’s arteritis (TA); how to treat?
  
  Pagina :730
  
  S.T. Tosounidou, D.C. Carruthers
- ·Contribution of anti-ferritin antibodies to the diagnosis of giant cell arteritis
  
  Pagina :730-731
  
  A. Regent, K.H. Ly, A. Blet, C. Agard, X. Puéchal, N. Tamas, C. Le-Jeunne, E. Vidal, L. Guillevin, L. Mouthon
  Riassunto Riassunto Mappa Mappa
- ·Increased migration and proliferation potential characterized vascular smooth muscle cells from patients with giant cell arteritis
  
  Pagina :731
  
  A. Regent, K. Ly, G. Clary, C. Philippe, B. Cédric, C. Le-Jeunne, E. Vidal, A. Brezin, V. Witko-Sarsat, L. Guillevin, L. Mouthon
- ·Takayasu arteritis in Tunisia: Clinical study of 34 cases
  
  Pagina :731
  
  I. Ben Ghorbel, N. Belfeki, S. Souissi, A. Hamzaoui, T. Ben Salem, M. Khanfir, M. Lamloum, M. Miled, H. Houman
- ·Radiological features in Takayasu’ arteritis in Tunisia. About 34 cases
  
  Pagina :731-732
  
  N. Belfeki, I. Ben Ghorbel, S. Souissi, A. Hamzaoui, T. Ben Salem, M. Khanfir, M. Lamloum, M. Miled, H. Houman
  Riassunto Riassunto Mappa Mappa
- ·Long-term outcome of 123 microscopic polyangiitis patients in a monocentric German cohort
  
  Pagina :732
  
  S. Schinke, E. Reinhold-Keller, M. Both, B. Nölle, M. Laudien, W. Gross, J. Holle
- ·The role of MPO-positive cells and MPO deposition in glomerular capillary injury in patients with various glomerulonephritis
  
  Pagina :732-733
  
  S. Kawashima, Y. Arimura, Y. Komagata, S. Kaname, A. Yamada
  Riassunto Riassunto Mappa Mappa
- ·Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan
  
  Pagina :733
  
  S. Furuta, A. Chaudhry, Y. Hamano, S. Fujimoto, H. Nagafuchi, S. Ozaki, H. Makino, S. Matsuo, T. Endo, E. Muso, C. Ito, E. Kusano, M. Yamagata, K. Ikeda, D. Kasiwakuma, I. Iwamoto, K. Westman, D. Jayne
- ·Prediction of outcome of treatment by gene expression profiling of peripheral blood in patients with microscopic polyangiitis
  
  Pagina :733
  
  A. Ishizu, U. Tomaru, T. Murai, T. Yamamoto, T. Atsumi, T. Yoshiki, H. Makino, S. Ozaki
- ·Serum C-reactive protein reflects the proportions of cellular crescent formation and glomerulosclerosis in patients with microscopic polyangiitis
  
  Pagina :734
  
  T. Iwakiri, Y. Matsuura, A. Yamashita, S. Uezono, S. Hisanaga, T. Tokura, K. Kitamura, Y. Asada, S. Fujimoto
- ·Unilateral vocal cord paralysis as initial manifestation of severe microscopic polyangiitis (MPA)
  
  Pagina :734
  
  L.F. Flores-Suárez, G. Tona
- ·Rapidly progressive glomerulonephritis is not the sole presentation of renal involvement in ANCA associated vasculitis
  
  Pagina :734-735
  
  C. Levi, E. Thervet, E. Guiard, L. Mouthon, C. Daniliuc, M. Roland, L. Guillevin, D. Nochy, C. Jacquot, A. Karras
  Riassunto Riassunto Mappa Mappa
- ·Abnormal glycosylation of serum IgG from patients with ANCA-associated systemic vasculitis: Relation to disease activity
  
  Pagina :735
  
  O. Lardinois, J. Hess, L. Deterding, L. Aybar, S. Hogan, J. Mcgregor, C. Poulton, Y. Hu, C. Henderson, D. Bunch, R. Falk
- ·Renal histopathological classification of ANCA associated glomerulonephritis: A validation study of 92 patients
  
  Pagina :735-736
  
  E. De Sousa Amorim, A. Ros Abando, A. Casian, D. Jayne
  Riassunto Riassunto Mappa Mappa
- ·Aortitis evidenced by PET-CT 18FDG in the setting of ANCA-associated vasculitis: About four cases
  
  Pagina :736
  
  T. Nguyen, E. Cogan, D. Blocklet, F. Vandergheynst
- ·The informational needs of patients with ANCA-vasculitis – a multinational study
  
  Pagina :736-737
  
  J. Mooney, P.A. Merkel, F. Poland, N. Spalding, D. Sheriff, P. Grayson, R. Richesson, R. Le Duc, D.G.I. Scott, R.A. Watts
  Riassunto Riassunto Mappa Mappa
- ·Proposal of an algorithm for the diagnosis and aetiologic identification of diffuse alveolar haemorrhage (DAH)
  
  Pagina :737
  
  C. Ramírez-Assad, F. Contreras-Rodríguez, J. Cedillo, E. Bautista, L.F. Flores-Suárez
- ·Validation of the Birmingham Vasculitis activity score (BVAS) and the Vasculitis Damage Index (VDI) in a population of patients with ANCA-associated vasculitis (AASV) in Mexico
  
  Pagina :737
  
  C. Ramírez-Assad, M.H. Cardiel, L.F. Flores-Suárez
- ·Illness perceptions and fatigue in systemic vasculitis
  
  Pagina :737-738
  
  P. Grayson, N. Amudala, C. Mcalear, R. Leduc, D. Shereff, R. Richesson, L. Fraenkel, P. Merkel
  Riassunto Riassunto Mappa Mappa
- ·Successful treatment with rituximab in patients with Schnitzler syndrome
  
  Pagina :738
  
  P. Novikov, E. Kuznetsova, V. Pulina, A. Meshkov, N. Nikiforova
- ·Rituximab and vascular function in granulomatosis with polyangiitis (GPA)
  
  Pagina :738-739
  
  A. Casian, K. Maki-Petaja, J. Cheriyan, A. Hubsch, I. Wilkinson, D. Jayne
  Riassunto Riassunto Mappa Mappa
- ·Serial chest high-resolution CT (HRCT) scans in patients with ANCA-associated vasculitis
  
  Pagina :739
  
  P. Konopasek, D. Altmanova, Z. Hruskova, E. Jancova, B. Svobodova, V. Tesar
- ·Association between thyroid disease and ANCA associated vasculitis
  
  Pagina :739-740
  
  M. Prendecki, A. Tanna, E. Clutterbuck, C. Pusey
  Riassunto Riassunto Mappa Mappa
- ·Single-organ gallbladder vasculitis: Characterization and distinction from systemic vasculitis involving the gallbladder. An analysis of 57 patients
  
  Pagina :740
  
  J. Hernández-Rodríguez, C.D. Tan, E.R. Rodríguez, G.S. Hoffman
- ·Weight loss – a common presentation in a rare disease. IgG4 related disease (IgG4 RD) is an emerging diagnosis not to miss
  
  Pagina :740-741
  
  S.T. Tosounidou, D.C. Carruthers
  Riassunto Riassunto Mappa Mappa
- ·Silica binds to LL-37 and CpG DNA complexes
  
  Pagina :741
  
  P.R. Hurtado, J. Nitschke, E. Hurtado-Perez, C.A. Peh
- ·Aneurysms in the view of rheumatology perspective
  
  Pagina :741
  
  O. Karadag, U. Kalyoncu, L. Kilic, E. Er, A.G. Er, I. Dogan, A. Akdogan, I. Ertenli
- ·IgA associated vasculitis (IgAV) – a 5-year retrospective study
  
  Pagina :741-742
  
  C. Gota, S. Billings, C. Langford
  Riassunto Riassunto Mappa Mappa
- ·Macrophage activation syndrome in vasculitis: An underrecognised complication?
  
  Pagina :742
  
  L. Damian, C. Cismaru, L. Ghib, M. Muresan, B. Stancu, M. Sfichi, I. Felea, I. Filipescu, S. Rednic, A. Bojan
- ·Retroperitoneal fibrosis at the onset of ANCA associated vasculitis: The risk of a delay in the diagnosis of vasculitis
  
  Pagina :742
  
  S. Possenti, F. Londrino, G. Jeannin, C. Salviani, G. Cancarini, G.A. Gregorini
- ·Positron emission tomography scanning in ANCA associated vasculitis
  
  Pagina :742
  
  M. Kemna, S. Vöö, P. Van Paassen, S. Timmermans, M. Van Kroonenburgh, J.W. Cohen Tervaert
- ·Circulating microRNAs in ANCA vasculitis correlate to renal function, hemoglobin and risk of relapse
  
  Pagina :743
  
  C. Skoglund, A.L. Carlsen, M. Weiner, T. Kurz, T. Hellmark, P. Eriksson, N. Heegaard, M. Segelmark
- ·Hemorrhagic emergency due to intrahepatic aneurism rupture in a patient with Polyateritis Nodosa after long time of episodic fever: A case report
  
  Pagina :743-744
  
  F. Silva, M. Cisternas, G. Maguida, M.I. Ruiz, P. Diaz, S. Gonzalez, J. Martinez, L. Meneses, L. Massardo
  Riassunto Riassunto Mappa Mappa
- ·Clinical characteristics of ANCA associated vasculitis in hispanic patients: Single centre experience in Chile
  
  Pagina :744
  
  M. Cisternas, M.J. Lira, F. Silva
- ·Long-term outcomes of patients with Reversible Cerebral Vasoconstriction Syndrome (RCVS)
  
  Pagina :744
  
  S. John, L. Calabrese, K. Uchino, S. Tepper, M. Stillman, R. Hajj-Ali
- ·Treatment related damage in the ANCA-associated vasculitides: An analysis of cohorts from the European Vasculitis Study Group (EUVAS) therapeutic trials
  
  Pagina :744-745
  
  J. Robson, H. Doll, O. Flossmann, S. Ravi, H. Lorraine, H. Peter, J. David, M. Chetan, W. Kerstin, L. Raashid
  Riassunto Riassunto Mappa Mappa
- ·Factors associated with long-term damage in the ANCA-associated vasculitides: An analysis of cohorts from the European vasculitis study group (EUVAS) therapeutic trials
  
  Pagina :745
  
  J. Robson, H. Doll, F. Oliver, S. Ravi, H. Lorraine, H. Peter, J. David, M. Chetan, W. Kerstin, L. Raashid
- ·Markers for work disability in ANCA-associated vasculitis
  
  Pagina :745-746
  
  N. Basu, A. Mcclean, L. Harper, M. Little, R. Luqmani, O. Flossmann, D. Jayne, N. Dhaun, V. Kumar, J. Mclaren, E. Amft, L. Erwig, G. Macfarlane, D. Reid, G. Jones
  Riassunto Riassunto Mappa Mappa
- ·Long-term outcome of GPA and MPA in a population based cohort
  
  Pagina :746
  
  R.A. Watts, J. Mooney, C. Mukhtyar, C. Sheehy, D.G.I. Scott
- ·ADAPTIV: A Delphi study to assess morbidity prevention and treatment in vasculitis
  
  Pagina :746-747
  
  N. Brown, D. Tooth, A. Summers, M. Venning
  Riassunto Riassunto Mappa Mappa
- ·Estimating renal survival using the ANCA-associated glomerulonephritis classification: A validation study
  
  Pagina :747-748
  
  B. Wilde, P. Van Paassen, P. Van Breda Vriesman, J.W. Cohen Tervaert, M. Hilhorst
  Riassunto Riassunto Mappa Mappa
- ·Towards an international standardized ENT disease activity score in GPA
  
  Pagina :748
  
  M. Martinez Del Pero, M. Laudien, N. Rasmussen
- ·Cardiovascular outcomes and prognostic predictors in ANCA-associated vasculitis
  
  Pagina :748-749
  
  C. Yuste, A. Casian, C. Jironda, D. Jayne
  Riassunto Riassunto Mappa Mappa
- ·The value of a patient global assessment for disease activity in granulomatosis with polyangiitis
  
  Pagina :749
  
  G. Tomasson, J.C. Davis, G.S. Hoffman, W.J. Mccune, U. Specks, R. Spiera, E.W. St. Clair, J.H. Stone, P.A. Merkel
- ·Patient reported outcomes in ANCA-associated vasculitis. A prospective comparison between BVAS and RAPID3 on an MDHAQ
  
  Pagina :749
  
  O. Elsallabi, J. Block
- ·Severe fatigue and psychological morbidity in ANCA-associated vasculitis
  
  Pagina :749-750
  
  A. Mcclean, N. Basu, D. Jones, M. Morgan, J. Bosch, L. Harper
  Riassunto Riassunto Mappa Mappa
- ·Severe fatigue in ANCA-associated vasculitis is associated with altered perception and reduced cardiovascular fitness
  
  Pagina :750
  
  A. Mcclean, N. Basu, D. Jones, M. Morgan, J. Bosch, L. Harper
- ·Predicting renal relapse with the histopathologic classification of ANCA-associated glomerulonephritis
  
  Pagina :750-751
  
  A. Göçeroğlu, R.A.F. De Lind Van Wijngaarden, A.E. Berden, K. Westman, O. Flossmann, M. Walsh, M. Fiocco, R. Wolterbeek, H.A. Hauer, D. Jayne, G. Gaskin, N. Rasmussen, L.H. Noël, F. Ferrario, R. Waldherr, C. Pusey, E.C. Hagen, J.A. Bruijn, I.M. Bajema
  Riassunto Riassunto Mappa Mappa
- ·Antineuthropil cytoplasmic autoantibody-associated vasculitis (AAV) in older patients (REVAS Study)
  
  Pagina :751
  
  R. Solans, L. Caminal, G. Fraile, L. Saez, J.J. Rios, M. Monica, X. Xavier, M. Monica, C.M. Jesus
- ·ANCA vasculitis and atypical hemolytic uremic syndrome: An association with poor outcome
  
  Pagina :752
  
  E. Gnappi, L. Signorini, A. Vaglio, F. Pilato, L. Manenti
- ·Long-term outcome of severe alveolar hemorrhage in ANCA-associated vasculitis: A retrospective cohort study
  
  Pagina :752
  
  Z. Hruskova, A. Casian, P. Konopasek, B. Svobodova, D. Frausova, V. Lanska, V. Tesar, D. Jayne
- ·Acute respiratory distress syndrome (ARDS) as primary manifestation in ANCA-associated vasculitis
  
  Pagina :752-753
  
  M. Dolch, M. Irlbeck, M. Wessely, S. Rau, L. Frey, U. Schönermarck
  Riassunto Riassunto Mappa Mappa
- ·Focal necrotizing and crescentic glomerulonephritis in patients with normal serum creatinine
  
  Pagina :753
  
  S.P. Mcadoo, A. Tanna, O. Randone, M. Griffith, J. Levy, T. Cook, T. Cairns, C. Pusey
- ·Clinical and pathological study on 34 patients with primary ANCA-associated systemic vasculitis with renal immune complex deposition
  
  Pagina :753
  
  X. Li, W. Zhang, X. Pan, N. Chen
- ·Long-term outcome of low dose cyclophosphamide (CYC) and plasma exchange (PLEX) induction in ANCA-associated vasculitis (AAV)
  
  Pagina :754
  
  W. Szpirt, E. Krarup, M. Egfjord
- ·Longitudinal ANCA measurements for predicting a relapse are useful in patients with severe disease but not in patients with limited disease
  
  Pagina :754
  
  M. Kemna, J. Damoiseaux, J. Austen, B. Winkens, J. Peters, P. Van Paassen, J.W. Cohen Tervaert
- ·Low %CD5+ B cells in patients with ANCA vasculitis portends a shorter time to relapse after rituximab
  
  Pagina :754-755
  
  D. Bunch, J. Mcgregor, L. Aybar, E. Studstill, Y. Hu, S. Hogan, K. Colby, C. Poulton, C. Mendoza, J. Schmitz, R. Falk, P. Nachman
  Riassunto Riassunto Mappa Mappa
- ·Monocyte chemoattractant protein-1 (MCP-1) in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis: Biomarker potential and association with polymorphisms in the MCP-1 and the CC chemokine receptor-2 (CCR2) gene
  
  Pagina :755
  
  N. Jönsson, L. Gunnarsson, A. Pettersson, S. Ohlsson
- ·Abundant neutrophil extracellular traps in thrombus of patient with microscopic polyangiitis
  
  Pagina :755
  
  D. Nakazawa, U. Tomaru, S. Jodo, S. Nishio, T. Atsumi, A. Ishizu
- ·Characterization of regulatory B cells in ANCA-associated vasculitis (AAV)
  
  Pagina :755-756
  
  N. Lepse, W.H. Abdulahad, A. Rutgers, C.A. Stegeman, C.G. Kallenberg, P. Heeringa
  Riassunto Riassunto Mappa Mappa
- ·Epitope analysis of anti-myeloperoxidase antibodies in patients with ANCA-associated vasculitis
  
  Pagina :756
  
  S.J. Gou, P.C. Xu, M. Chen, M.H. Zhao
- ·Investigating the microRNA signature of ANCA associated vasculitis
  
  Pagina :756-757
  
  N. Brown, S. Harris, M. Venning, P. Brenchley
  Riassunto Riassunto Mappa Mappa
- ·The interaction between C5a and sphingosine-1-phosphate in neutrophils for ANCA-mediated activation
  
  Pagina :757
  
  J. Hao, C. Wang, M. Chen, M.H. Zhao
- ·Circulating level of high mobility group box-1 is associated with disease activity in antineutrophil cytoplasmic autoantibody-associated vasculitis
  
  Pagina :757-758
  
  C. Wang, M. Chen
  Riassunto Riassunto Mappa Mappa
- ·Pentraxin-3 and soluble tumor necrosis factor-like weak inducer of apoptosis (s-Tweak) in anti-neutrophil antibody associated vasculitis (AAV)
  
  Pagina :758
  
  M. Wendt, O. Borjesson, A. Avik, J. Bratt, A.R. Qureshi, I. Gunnarsson, A. Bruchfeld
- ·Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracil-induced ANCA-associated vasculitis
  
  Pagina :758
  
  C. Wang, M. Chen
- ·IL-10 producing regulatory B-cells are diminished in ANCA-associated vasculitis
  
  Pagina :758-759
  
  B. Wilde, M. Thewissen, P. Van Paassen, M. Hilhorst, J. Damoiseaux, O. Witzke, J.W. Cohen Tervaert
  Riassunto Riassunto Mappa Mappa
- ·Interleukin-21, B cell activating factor and unmethylated CpG oligodeoxynucleotides synergize in promoting anti-Proteinase 3 autoantibody production in vitro
  
  Pagina :759
  
  N. Lepse, J. Land, A. Rutgers, C.G. Kallenberg, C.A. Stegeman, W.H. Abdulahad, P. Heeringa
- ·DNA from neutrophil extracellular traps is hypomethylated
  
  Pagina :759
  
  E. Hurtado, J. Nitschke, P. Hurtado, C.A. Peh
- ·ANCA reactive B cells and neutrophils cross-talk in the pathogenesis of AAV: A model proposal
  
  Pagina :760
  
  P.R. Hurtado, J. Nitschke, E. Hurtado-Perez, C.A. Peh
- ·Tissue destruction in granulomatosis with polyangiitis: Common histological pattern in mice and men
  
  Pagina :760
  
  N. Kesel, U. Schumacher, M. Laudien, K. Holl-Ulrich, W. Gross, A. Müller, S. Ullrich
- ·Coagulation activity in renal ANCA-positive vasculitis
  
  Pagina :760-761
  
  A.E. Ekstrand, R.L. Lassila, L.J.K. Joutsi-Korhonen, A.S. Salmela
  Riassunto Riassunto Mappa Mappa
- ·Galactosylation and sialylation of anti-proteinase 3 antibodies in granulomatosis with polyangiitis is associated with increased inflammatory cytokines
  
  Pagina :761
  
  M. Morgan, K. Stavenhagen, C. Koeleman, A. Hipgrave-Ederveen, L. Harper, B. Jacobs, C. Savage, R. Jefferis, A. Deelder, M. Wuhrer
- ·LAMP-2, a potential novel receptor on human monocytes derived dendritic cells (MDDC)
  
  Pagina :761-762
  
  D.L. Leone
  Riassunto Riassunto Mappa Mappa
- ·Autoantibodies for several antigens in neutrophil cytoplasm other than PR3 and MPO also promote release of NETs from neutrophils
  
  Pagina :762
  
  Y. Komagata, S. Amonpatumrat, K. Sano, S. Kawashima, S. Kaname, Y. Arimura, A. Yamada
- ·Antibodies to LAMP-2 alter lysosome function and attenuate chaperone-mediated autophagy in human macrophages
  
  Pagina :762
  
  K. Sintiprungrat, V. Thongboonkerd, P. Andrea, R. Kain, A.J. Rees
- ·Urinary HMGB1 levels are associated with CD4+ T-cells in urine in patients with ANCA-associated vasculitis and active nephritis
  
  Pagina :762-763
  
  A.W. Silva De Souza, W.H. Abdulahad, J. Westra, P. Sosicka, P.C. Limburg, M. Bijl, C.A. Stegeman, C.G.M. Kallenberg
  Riassunto Riassunto Mappa Mappa
- ·HMGB1 in ANCA-associated vasculitis: A longitudinal study
  
  Pagina :763
  
  A.W. Silva De Souza, J. Westra, J. Bijzet, P.C. Limburg, M. Bijl, C.A. Stegeman, C.G.M. Kallenberg
- ·Functionally effect regulatory B cells in patients with active ANCA vasculitis
  
  Pagina :763
  
  L. Aybar, S. Hogan, J. Mcgregor, J. Vick, C. Poulton, Y. Hu, C. Henderson, R. Falk, D. Bunch
- ·In vitro neutrophil activation by ANCA from patients with ANCA associated vasculitis; degranulation and oxidative burst
  
  Pagina :764
  
  S. Ohlsson, S. Ohlsson, L. Holm, L. Gunnarsson, T. Hellmark
- ·Potential defect in annexin-A1-dependent anti-inflammatory mechanisms in GPA: Its cleavage by PR3 and its inhibition by autoantibodies
  
  Pagina :764
  
  M. Pederzoli-Ribeil, A. Regent, A. Millet, F. D’acquisto, L. Guillevin, M. Perretti, L. Mouthon, V. Witko-Sarsat
- ·Thrombotic vasculopathy with neovascularisation associated with probably levamisole-contaminated cocaine: Report of 2 cases
  
  Pagina :764-765
  
  L.F. Flores-Suárez, M.A. Martínez-Velasco, S. Toussaint-Caire, A. Rodríguez-Carreón, M. Díaz-Lozano, K. Sánchez-Armendáriz
  Riassunto Riassunto Mappa Mappa
- ·Cutaneous hypersensitivity vasculitis associated with visceral Mycobacterium tuberculosis infection: A report of three cases
  
  Pagina :765
  
  M. Areses, C. Perez, J. Ibañez, M. Fanlo, M. Abinzano, M. Cia
- ·Severe diffuse alveolar haemorrhage after TAVI with CoreValve in patient with AAV and Horton disease in remission. An immuno-allergic reaction?
  
  Pagina :765-766
  
  G.A. Gregorini, C. Fiorina, M.F. Bonetti
  Riassunto Riassunto Mappa Mappa
- ·Microscopic vasculitis associated to Sjögren’s syndrome. About 4 cases
  
  Pagina :766
  
  I. Ben Ghorbel, N. Belfeki, T. Ben Salem, A. Hamzaoui, M. Khanfir, M. Lamloum, M. Miled, H. houman
- ·Quantifying the effect of rituximab on changes in serum immunoglobulin G
  
  Pagina :766-767
  
  D. Roberts, R. Smith, R. Jones, F. Alberici, H. Marco, D. Jayne
  Riassunto Riassunto Mappa Mappa
- ·Risk of malignancy with long-term immunosuppression in ANCA-associated vasculitis
  
  Pagina :767
  
  C. Rahmattulla, A. Göçeroğlu, M.E.J. Reinders, E.C. Hagen, J.A. Bruijn, I.M. Bajema
- ·Infectious complications related to treatment in an inception cohort of antineutrophil cytoplasmic antibody associated vasculitis
  
  Pagina :767
  
  J. Mcgregor, R. Negrete-Lopez, C. Poulton, J. Kidd, S. Weaver, L. Goetz, Y. Hu, P. Nachman, R. Falk, S. Hogan
- ·Cyclophosphamide effect on immunoglobulins levels in AAV patients treated with long-term pre-emptive rituximab maintenance
  
  Pagina :767-768
  
  E. Besada, W. Koldingsnes, J. Nossent
  Riassunto Riassunto Mappa Mappa
- ·An international, open label, randomised controlled trial comparing rituximab with azathioprine as maintenance therapy in relapsing ANCA-associated vasculitis (RITAZAREM)
  
  Pagina :768
  
  D. Jayne, R. Smith, P. Merkel
- ·C5aR inhibitor on leukocytes exploratory ANCA associated renal vasculitis (CLEAR) clinical trial with orally administered CCX168
  
  Pagina :768-769
  
  A. Bruchfeld, M. Schaier, M. Jadoul, D. Selga, I. Szombati, M. Venning, P. Hamilton, K. Ciechanowski, C. Hugo, M. Segelmark, O. Viklicky, J. Jaen, T. Schall, P. Bekker
  Riassunto Riassunto Mappa Mappa
- ·Lack of efficacy of tocilizumab in mucocutaneous Behçet’s syndrome: Report of two cases
  
  Pagina :769
  
  A.P. Diamantopoulos, G. Hatemi
- ·Improving the quality and safety of intravenous cyclophosphamide (IV CYC): A regional audit of a best-practice protocol
  
  Pagina :769
  
  F. Rees, S. Varughese, M. Regan, K. Lim, C. Symonds, P. Lanyon
- ·An open-label trial of abatacept in mild relapsing granulomatosis with polyangiitis (Wegener’s) (GPA)
  
  Pagina :770
  
  C. Langford, D. Cuthbertson, G. Hoffman, J. Krischer, C. Mc Alear, P. Monach, P. Seo, U. Specks, S. Ytterberg, P. Merkel
- ·Lactoferrin inhibits formation of neutrophil extracellular traps in inflammation
  
  Pagina :770
  
  K. Okubo, M. Kamiya, Y. Urano, M. Nangaku, T. Fujita, J. Hirahashi
- ·Incidence of coronary aneurysms in children with Kawasaki disease after early treatment with IVIG and aspirin: Report of 55 cases
  
  Pagina :771
  
  C. Romero, C. Perez, P. Martinez, R. Urabayen, P. Fanlo, T. Carrasquer
- ·Co-trimoxazole monotherapy as induction therapy for localized granulomatosis with polyangiitis
  
  Pagina :771
  
  J. Tuin, J.S. Sanders, C.A. Stegeman
- ·Successful treatment of refractory cutaneous ulcer associated with polyarteritis nodosa with bosentan
  
  Pagina :771-772
  
  P. Fanlo, L. Loidi, S. Clemos, A. Villanueva, E. Huarte, M. Mellado, T. Elias, C. Perez
  Riassunto Riassunto Mappa Mappa
- ·Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis: A randomized controlled trial. PEXIVAS
  
  Pagina :772
  
  B. Brezina, D. Jayne
- ·Fixed-interval repeat dose rituximab improves abnormalities in the periperhal B cell compartment and reduces relapse rates in ANCA associated vasculitis
  
  Pagina :772
  
  E. Wallin, R. Smith, R. Jones, D. Jayne, K. Smith
- ·Predictors of treatment resistance and relapse in Chinese patients with antineutrophil cytoplasmic antibody-associated disease
  
  Pagina :772-773
  
  Y. Cao
  Riassunto Riassunto Mappa Mappa
- ·Induction treatment of ANCA associated vasculitis with a single dose of rituximab
  
  Pagina :773
  
  M. Little, T. Turner-Stokes, E. Sandhu, N. Stolagiewicz, C. Ashley, A. Salama, A. Burns, A. Howie, D. Dinneen
- ·Therapeutic drug monitoring detects high interpatient variability in response to mycophenolic acid treatment in patients with ANCA-associated vasculitis
  
  Pagina :773-774
  
  M. Schaier, S. Bönisch-Schmidt, V. Schwenger, M. Zeier, C. Sommerer
  Riassunto Riassunto Mappa Mappa
- ·Time to remission and relapse following rituximab in an inception cohort of antineutrophil cytoplasmic antibody associated vasculitis
  
  Pagina :774
  
  M.E. Studstill, J. Mcgregor, C. Poulton, Y. Hu, P. Nachman, R. Falk, S. Hogan
- ·Rituximab use in patients with ANCA-associated vasculitis: Clinical efficacy and impact on immunological parameters
  
  Pagina :774
  
  Z. Chocova, Z. Hruskova, H. Mareckova, B. Svobodova, V. Bednarova, E. Jancova, R. Rysava, V. Tesar
- ·Maintenance therapy using rituximab-induced continuous B cell depletion for ANCA vasculitis
  
  Pagina :774-775
  
  W. Pendergraft, F. Cortazar, J. Wenger, A. Murphy, K. Laliberte, J. Niles
  Riassunto Riassunto Mappa Mappa
- ·What everybody is doing but no one is talking about: Complementary and alternative medicine (CAM) prevalence in the ANCA SVV population
  
  Pagina :775
  
  E. Berg, J. Mcgregor, M. Burkart, C. Poulton, S. Hogan
- ·Long term follow up of patients who received repeat dose rituximab as maintenance therapy for ANCA associated vasculitis (AAV)
  
  Pagina :775-776
  
  R. Smith, F. Alberici, R. Jones, D. Jayne
  Riassunto Riassunto Mappa Mappa
- ·Re-treatment with rituximab in ANCA-associated vasculitis only in the presence of clinical relapse: A single centre experience
  
  Pagina :776
  
  G. Jeannin, C. Salviani, S. Possenti, A. Regazzoli, F. Allegri, G. Cancarini, G.A. Gregorini
- ·Gestational rituximab exposure in women with vasculitis
  
  Pagina :776-777
  
  W. Pendergraft, M. Mcgrath, A. Murphy, P. Murphy, K. Laliberte, J. Niles
  Riassunto Riassunto Mappa Mappa
- ·Use of rituximab in Hispanic patients with severe ANCA associated vasculitis: A 6 years experience in a tertiary centre in Chile
  
  Pagina :777
  
  F. Silva, L. Massardo, M. Mimica, P. Pastenes, M. Cisternas, F. Radrigan, M. Gutierrez
- ·Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in Granulomatosis with Polyangiitis: Results from a single centre
  
  Pagina :777
  
  E. Besada, W. Koldingsnes, J. Nossent
- ·Use of an empirically derived cyclophosphamide dosing nomogram for treatment of vasculitis
  
  Pagina :777-778
  
  A. Salama, M.D. Gabrel, A. Koteci, L. Harper, D. Jayne, D. Nitsch, R. Daniel, E. Naylor, M. Little
  Riassunto Riassunto Mappa Mappa
- ·Retreatment with Rituximab in the RAVE Trial
  
  Pagina :778
  
  E. Miloslavsky, U. Specks, P. Merkel, P. Seo, R. Spiera, C. Langford, G. Hoffman, C. Kallenberg, W. St. Clair, N. Tchao, L. Ding, D. Ikle, B. Jepson, P. Brunetta, J. Stone
- ·Rituximab versus azathioprine for maintenance in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (MAINRITSAN): Follow-up at 34 months
  
  Pagina :778-779
  
  B. Terrier, C. Pagnoux, A. Karras, C. Khouatra, O. Aumaitre, P. Cohen, F. Maurier, O. Decaux, H. Desmurs-Clavel, P. Gobert, T. Quemeneur, C. Blanchard-Delaunay, P. Godmer, X. Puechal, L. Mouthon, L. Guillevin
  Riassunto Riassunto Mappa Mappa
- ·Safety of remission induction with rituximab versus cyclophosphamide in patients 65 and older with severe ANCA-associated vasculitis
  
  Pagina :779-780
  
  E. Miloslavsky, U. Specks, P. Merkel, P. Seo, R. Spiera, C. Langford, G. Hoffman, C. Kallenberg, W. St. Clair, N. Tchao, L. Ding, D. Ikle, B. Jepson, P. Brunetta, J. Stone
  Riassunto Riassunto Mappa Mappa
Index des auteurs
- ·Index auteurs
  
  Pagina :782-790
  
  Riassunto Riassunto Mappa Mappa

@@150455@@ Voir plus

Il mio account

Creare un account

Aide & support

Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.

Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.